Speaking Engagements

Schellenberg Wittmer Hosts a Roundtable on Transactional Challenges in Life Sciences


Schellenberg Wittmer hosted a roundtable on the Transactional Challenges in Life Sciences.

Structuring a deal in the life sciences sector remains challenging: Investment regimes, regulatory framework, cost pressure on R&D activities, evolving commercial models and rising costs of healthcare require in-depth legal and industry know-how.

Members of our Mergers & Acquisitions and Life Sciences practice groups  - Lorenza Ferrari Hofer, Pascal Hubli, Marcel Jakob and Oliver Triebold - presented and discussed legal questions arising out of life sciences transactions, with a focus on venture deals, stock exchange listings, and the regulatory framework.


Stay up to date!

*Required fields

Newsletters & Newsflashes

Monthly selected key topics from our practice areas, sectors and industries, plus newsflashes on recent developments.


Monthly email with the latest updates and summaries of the Swiss Federal Supreme Court's case law in arbitration matters.
Regular insights into Swiss and international trends and legal developments in the construction industry.
Regular insights and updates on key developments in the rapidly changing landscape of Environmental, Social and Corporate Governance disputes.
Concise analysis of key trends in the fast-moving world of corporate governance for board members of Swiss companies.
A regular look from a unique M&A perspective at legal changes, economic developments and societal trends in Switzerland.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.